Journal Article Summary

The article investigates the effects of losartan, a medication typically used for high blood pressure, on liver fibrosis in patients with chronic hepatitis C. This topic is significant because liver fibrosis can lead to severe complications, including cirrhosis and liver cancer, making it crucial to find effective treatments for those who do not respond to standard therapies. The study aims to explore whether losartan can improve liver health in patients who have not benefited from traditional treatments.

In this pilot study, fourteen patients with chronic hepatitis C who were either non-responders to standard treatment or had contraindications to it were given losartan for six months. The researchers conducted liver biopsies and various tests to assess liver and kidney function before and after the treatment. The results showed that patients taking losartan experienced a significant reduction in liver fibrosis, while those in the control group, who did not receive the medication, showed an increase in fibrosis.

However, the study has limitations, including a small sample size and the lack of a long-term follow-up to assess the lasting effects of losartan. Patients should be aware that while the findings are promising, they are preliminary and should not replace standard medical advice. It is essential for individuals with chronic hepatitis C to discuss any potential treatments, including losartan, with their healthcare provider to ensure safe and appropriate care tailored to their specific condition.

Medication Safety Note

This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.

Article Cited

  1. Sookoian Silvia, FernƔndez Marƭa Alejandra, CastaƱo Gustavo. Effects of six months losartan administration on liver fibrosis in chronic hepatitis C patients: A pilot study. World Journal of Gastroenterology 2005. DOI: 10.3748/wjg.v11.i48.7560. PMID: 16437678. PMCID: PMC4727214.

Featured Pill Pals Product

Pill PalsĀ® is THE Express Pharmacy. Our Nationwide Pharmacy Network was created with the mission of helping you make SENSE of your medsā„¢. As a Pharmacy Benefits Management organization, Pill PalsĀ® gives patients the best cash prices on all meds. Pill PalsĀ® is part of The Health PalsĀ® Company (Health PalsĀ®, Med PalsĀ®, Skin PalsĀ® etc), a vertically integrated Healthcare System that provides cost effective Medical and Pharmacy services to Employers, Patients, and more. For more information, please email [email protected]